DNA-based immunization against hepatitis B virus

Springer Seminars in Immunopathology

Volumn 19, Issue 2, 1997, Pages 195-209

  Davis, Heather L ^a,b   Brazolot Millan, Cynthia L ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

CHIMPANZEE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; ANIMALS, NEWBORN; CHILD; EVALUATION STUDIES; FEMALE; GENETIC VECTORS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INFANT, NEWBORN; MALE; MICE; MICE, TRANSGENIC; PAN TROGLODYTES; PREGNANCY; SAFETY; VACCINATION; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 0030669176     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00870268     Document Type: Review

References (52)

1. Alberti A, Cavalletto D, Pontisso P, Chemello L, Tagariello G, Belussi F (1988) Antibody response to pre-S2 and hepatitis B virus induced liver damage. Lancet 25: 1421
2. Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C (1985) Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 230: 1160
3. Buynak EB, Roehm RR, Tytell AA, Bertland AU, Lampson GP, Hilleman MR (1976) Development and chimpanzee testing of a vaccine against human hepatitis B. Proc Soc Exp Biol Med 151: 694
4. Coates RA, Halliday ML, Rankin JG, Stewart JD, Bristow NJ, Granero R, West DJ (1988) Immunogenicity and safely of a yeast-derived recombinant DNA hepatitis B vaccine in health care workers. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 1038-1042
5. Centers for Disease Control (1987) Recommendations of the Immunization Practises Advisory Committee Update on hepatitis B prevention. MMWR 36: 353
6. Davis HL, Demeneix BA, Quantin B, Coulombe J, Whalen RG (1993) Plasmid DNA is superior to viral vectors for direct gene transfer in adult mouse skeletal muscle. Hum Gene Ther 4: 733
7. Davis HL, Michel M-L, Whalen RG (1993) DNA based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum Mol Genet 2: 1847
8. Davis HL, Michel M-L, Mancini M, Schleef M, Whalen RG (1994) Direct gene transfer in muscle with plasmid DNA for the purpose of nucleic acid immunization. Vaccine 12: 1503
9. Davis HL, Schirmbeck R, Reimann J, Whalen RG (1995) DNA-mediated immunization in mice induces a potent MHC class-I restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 6: 1447
10. Davis HL, Mancini M, Michel M-L, Whalen RG (1996) DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine 14: 910
11. Davis HL, McCluskie MJ, Gerin JL, Purcell RH (1996) DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 93: 7213
12. Davis HL, Brazolot Millan CL, Watkins SC (1997) Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther 4: 181
13. Ganem D, Varmus HE (1987) The molecular biology of the hepatitis B viruses. Annu Rev Biochem 56: 651
14. Gerety RJ (1988) Recombinant hepatitis B vaccines. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 1017-1024
15. Gerin JL, Purcell RH, Lerner RA (1985) Use of synthetic peptides to identify protective epitopes of the heptitis B surface antigen. Vaccines 85. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 235-239
16. Gerlich WH, Bruss V (1993) Functions of hepatitis B virus proteins and molecular targets for protective immunity. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 41-82
17. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV (1994) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 91: 3764
18. Hadler SC, Margolis HS (1993) Epidemiology of hepatitis B virus infection. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 141-158
19. Hibberd PL, Rubin RH, Dienstag JL (1993) Needs unfulfilled by current hepatitis B vaccines. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 323-336
20. Hilleman MR (1993) Plasma-derived hepatitis B vaccine: a breakthrough in preventive medicine. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 17-40
21. Itoh Y, Takai E, Ohnuma H, Kitajima K, Tsuda F, Machida A, Mishiro S, Nakamura T, Miyakawa Y, Mayumi M (1986) A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci USA 83: 9174
22. Iwarson S, Tabor E, Thomas HC, Snoy P, Gerety RJ (1985) Protection against hepatitis B virus infection by immunization with hepatitis B core antigen. Gastroenterology 88: 763
23. Kane MA (1993) Global control of hepatitis B through universal infant immunization. In: Ellis RW (ed) Hepatitis B vaccines in clinical practise. Dekker, New York, pp 309-322
24. Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546
25. Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D (1992) The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 175: 495
26. Lubeck MD, Davis AR, Chengalvala M, Natuk RJ, Morin JE, Molnar-Kimber K, Mason BB, Bhat BM, Mizutani S, Hung PP, Purcell RH (1989) Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc Natl Acad Sci USA 86: 6763
27. Mancini M, Hadchouel M, Tiollais P, Pourcel C, Michel M-L (1993) Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg. J Med Virol 39: 67
28. Maneini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel M-L (1996) DNA-mediated immunization breaks tolerance in a transgenic mouse model of hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA 93: 12496
29. Maugh TH (1980) Hepatitis B vaccine passes first major test. Science 210: 760
30. Maupas P, Goudeau A, Coursaget P, Drucker J (1976) Immunization against hepatitis B in man. Lancet 1: 1367
31. Michel M-L, Pontisso P, Sobczak E, Malpièce Y, Streeck RE, Tiollais P (1984) Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci USA 81: 7708
32. Michel M-L, Davis HL, Schleef M, Maneini M, Tiollais P, Whalen RG (1995) DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 92: 5307
33. Milich DR (1988) T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 9: 380
34. Moss B, Smith GL, Gerin JL, Purcell RH (1984) Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 311: 67
35. Murray K, Bruce SA, Hinnen A, Wingfield P, Erd PMCA van, Reus A de, Schellekens H (1984) Hepatitis B virus antigens made in microbial cells immunize against viral infection. EMBO J 3: 645
36. Neurath AR, Kent SBH, Strick N, Taylor P, Stevens CE (1985) Hepatitis B virus contains pre-S geneencoded domains. Nature 315: 154
37. Neurath AR, Kent SBH, Parker K, Prince AM, Strick N, Brotman B, Sproul P (1986) Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope arc virus-neutralizing. Vaccine 4: 35
38. Prince AM (1981) The use of chimpanzees in biomedical research. US Department of Health and Human Services: Trends in bioassay methodology in vivo, in vitro and mathematical approaches. NIH publication no. 82-2382. NIH, Bethesda, pp 81-98
39. Prince AM, Whalen RG, Brotman B (1997) Successful nucleic acid based immunization of newborn chimpanzees against HBV. Vaccine 15: 916
40. Purcell RH, Gerin JL (1975) Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci 270: 395
41. Purcell RH, Gerin JL (1987) Hepatitis B vaccines past present and future: lessons for AIDS vaccine development. In: Robinson W, Koike K, Will H (eds) Hepadna viruses. Liss, New York, pp 465-479
42. Reesink-Brongers EE, Reesink HW, Brummelhuis HGJ, Schut BJT, Dees PJ, Lelie PN, Raap AK, Wilson-de Stürler LA, Aken WG van, Balner H, Ecrd PMCA van, Schie TC van, Stitz LW, Steenis B van, Feltkamp-Vroom TM (1982) Preparation and evaluation of heat-inactivated HBsAg as a vaccine against hepatitis B. In: Szmuness W, Alter HJ, Maynard JE (eds) Viral Hepatitis 1981 International Symposium. The Franklin Institute Press, Philadelphia, pp 437-450
43. Ridge JP, Fuchs EJ, Matzinger P (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271: 1723
44. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen M-D, Silverman GJ, Lotz M, Carson DA, Raz E (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 353
45. + cytotoxic T lymphocyte responses in vivo. J Immunol 152: 1110
46. Stephenne J (1988) Recombinant versus plasma-derived hepatitis B vaccines: issues of safety immunogenicity and cost-effectiveness. Vaccine 6: 299
47. Tang D, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356: 152
48. Thornton GB, Milich DR, Chisari F, Mitamura K, Kent SB, Neurath R, Purcell RH, Gerin JL (1987) Immune response in primates to the pre-S2 region of hepatitis B surface antigen: identification of a protective determinant. In: Chanock RM, Lerner RA, Brown F, Ginsberg H (eds) Vaccines 87. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 77-80
49. Tiollais P, Buendia M-A (1991) Hepatitis B virus. Sci Am 264: 48
50. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347
51. Wolff JA, Malone RW, Williams P, Chong W, Ascadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465
52. Yano M, Tashiro A (1988) Clinical evaluation of recombinant yeast-derived hepatitis B vaccine. In Zuckerman AJ (ed) Viral hepatitis and liver disease. Liss, New York, pp 1050-1052